Genmab A/S Says Baillie Gifford & Co Held The Voting Rights To 3,301,530 Shares In Genmab A/S, Which Amounts To 4.99% Of The Share Capital And Voting Rights As Of October 3, 2024
Portfolio Pulse from Benzinga Newsdesk
Genmab A/S announced that Baillie Gifford & Co holds 4.99% of its share capital and voting rights, amounting to 3,301,530 shares as of October 3, 2024.
October 04, 2024 | 5:59 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Genmab A/S disclosed that Baillie Gifford & Co holds 4.99% of its shares, indicating significant institutional interest.
The announcement of Baillie Gifford & Co holding a significant stake in Genmab A/S suggests strong institutional confidence, which could positively influence investor sentiment and potentially lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100